Paul Stoffels - Wikipedia
网页Paul Stoffels is a Belgian doctor and pharmaceutical executive who co-founded Tibotec and Virco and led Janssen's global virology franchise. He is also the CEO of Galapagos since 2022 and received the Louis Pasteur Leadership Award in 2020.
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and …
网页2021年10月12日 · NEW BRUNSWICK, N.J. (October 12, 2021) – Johnson & Johnson (NYSE: JNJ) today announced that Paul Stoffels M.D., currently Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson, will retire from the Company effective December 31, 2021.
Paul Stoffels - Galapagos
网页Paul Stoffels is the Chief Executive Officer and Chairman of the Board of Directors of Galapagos, a biotech company. He was previously the Vice Chairman and Chief Scientific Officer of Johnson & Johnson, where he led the development of several innovative medicines, including HIV treatments.
Paul Stoffels, MD - Galapagos - LinkedIn
网页View Paul Stoffels, MD’s profile on LinkedIn, a professional community of 1 billion members. Paul Stoffels is a visionary leader who inspires and drives transformational innovation… ·...
- 人脉数: 16
- 位置: Galapagos
Galapagos appoints Paul Stoffels as Chief Executive Officer
网页2022年1月26日 · Galapagos appoints Paul Stoffels as Chief Executive Officer. Succeeds current Chief Executive Officer and co-founder Onno van de Stolpe, following planned retirement. Recognized as inspirational industry leader with exceptional R&D as well as global executive experience, and a strong focus on …
Read the Statement Paul Stoffels, M.D., Delivered on the …
网页2021年7月15日 · Paul Stoffels is Chief Scientific Officer at Johnson & Johnson and a life-long researcher in the search to eliminate HIV from the world. He shares his personal and professional journey, the progress and challenges in HIV treatment and prevention, and the need for collaboration and innovation.
Galapagos' new CEO Paul Stoffels wields axe in bid to go 'forward ...
网页2024年9月15日 · When long-serving Johnson & Johnson R&D chief Paul Stoffels cut short his retirement to take the helm at Galapagos earlier this year, it was clear he faced a challenge to steer the troubled...
'Up to Paul now': Galapagos' new CEO Stoffels jumps ... - Fierce …
网页2022年1月27日 · Galapagos' new CEO, Paul Stoffels, M.D., is ready to jump into acquisition and partnership talks and review new chief science officer candidates as he oversees a much-needed turnaround for the...
Dr. Paul Stoffels, Vice Chairman of the Executive Committee …
网页2021年10月12日 · As the Vice Chairman of the Executive Committee and Chief Scientific Officer, Dr. Stoffels spearheaded the company's research and product pipeline leading teams across sectors to set the company...
Paul Stoffels - CEO & Chair at Galapagos - The Org
网页Dr. Paul Stoffels joined Galapagos as CEO* in April 2022. Prior to that, he was Vice Chairman of the Executive Committee and CSO of Johnson & Johnson, where he set the company wide innovation agenda and led the pharmaceutical R&D pipeline as well as the external initiatives.